Home › Funds › ORBIMED ADVISORS LLC › SION

ORBIMED ADVISORS LLC position in SION

SIONNA THERAPEUTICS INC · Health Care

ORBIMED ADVISORS LLC reported holding 2,555,877 shares of SION (SIONNA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$112.4M, representing 2.26% of its reported portfolio and ranking #8 among its reported holdings. ORBIMED ADVISORS LLC has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)2.56M sh
Reported value held$112.43M
Portfolio Weight2.26%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's SION position evolved

ORBIMED ADVISORS LLC first disclosed a stake in SION in Q1 2025 at 3,704,959 shares (US$38.8M). The position peaked in Q4 2025 at 3,561,655 shares, worth US$146.5M. Across 6 filings, ORBIMED ADVISORS LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 2,555,877 shares valued at US$112.4M — a reduction of -974,825 shares quarter over quarter.. Notable position changes include a 28% trim in Q2 2026 (shares fell 88% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.70M $38.75M New
Q2 2025 3.70M $64.28M Hold
Q3 2025 3.70M $108.96M Hold
Q4 2025 3.56M $146.53M Reduce
Q1 2026 3.53M $141.55M Reduce
Q2 2026 2.56M $112.43M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SION and 13F data

SION (SIONNA THERAPEUTICS INC) is a Health Care company. 86 other funds we track also report a position in SION — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$435.7M), TPG GP A, LLC (US$285.7M), Atlas Venture Life Science Advisors, LLC (US$131.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SION

All SION fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held SION?

ORBIMED ADVISORS LLC has disclosed SION holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is ORBIMED ADVISORS LLC's current position in SION?

As of Q2 2026, ORBIMED ADVISORS LLC holds 2.56M shares of SION (SIONNA THERAPEUTICS INC), valued at $112.43M, representing 2.26% of its reported portfolio and ranking #8.

Has ORBIMED ADVISORS LLC been buying or selling SION?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in SION. The position peaked in Q4 2025 at 3.56M shares.

Which other funds hold SION?

Other major institutional holders of SION include RA CAPITAL MANAGEMENT, L.P., TPG GP A, LLC, Atlas Venture Life Science Advisors, LLC, among 86 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.